In healthy individuals performing constant-load exercise at intensities above the lactate threshold a secondary rise in pulmonary oxygen uptake (V O 2 ) occurs. V O 2 reaches a maximum and exhaustion rapidly prevails for a range of work rates lower than the maximal work rate achieved during a conventional rapid-incremental test. This phenomenon is called the slow component (SC) of V O 2 kinetics and represents an increase in V O 2 without an increase in work rate. Although still under debate, the magnitude of the SC is believed to be associated with the percentage of type II muscle fibres and their recruitment. In this study we investigated the relationship between the magnitude of the relative SC, citrate synthase activity, UCP2 and UCP3 mRNA levels and muscle fibre composition in both endurance-trained and recreationally active subjects. METHOD: The magnitude of the relative SC was measured in 12 endurance-trained (Tr) and 15 recreationally active (RA) male subjects. The magnitude of the relative SC was determined as the difference between the end-exercise V O 2 and 3 min V O 2 divided by the difference between end-exercise V O 2 and baseline V O 2 . UCP2 and UCP3 mRNA expression in the vastus lateralis was measured by RT-PCR with b-actin mRNA used as an internal control. These values were also normalized against cytochromeb mRNA to control for training induced changes in mitochondria when comparing the Tr and RA groups. Type I, IIa and IIx skeletal muscle fibre composition was determined using a routine myosin ATPase histochemical staining technique. Citrate synthase (CS) activity was measured using spectrophotometric detection.
Introduction
In healthy individuals performing submaximal exercise at intensities above the lactate threshold (LT) there is a secondary rise in pulmonary oxygen uptake (V O 2 ) without an increase in work rate. The term given to this secondary rise in the V O 2 response is the slow component (SC) of V O 2 kinetics. 1 The SC causes a delay and=or a failure to achieve steady-state V O 2 and is associated with premature fatigue. The gradual increase in V O 2 for the same external mechanical work, as indicated by the SC, suggests a possible decrease in mechanical efficiency and=or a reduction in the efficiency of aerobic adenosine triphosphate (ATP) production when exercising at work rates which delay and=or inhibit steadystate V O 2 .
At present the exact mechanisms causing the SC during high intensity submaximal exercise are not known. It has been reported that 86% of the SC occurs within the contracting muscle, 2 and other studies have observed correlations between the magnitude of the SC and the percentage 3 and recruitment 4 of type II muscle fibres. Furthermore, the ratio of phosphate produced per oxygen consumed (P=O ratio) is 18% lower in isolated mitochondria from type II compared to type I muscle, which suggests uncoupling of mitochondrial respiration. 5 Endurance training between 2 and 8 weeks has been observed to reduce the size of the SC, 6, 7 however it is unlikely that changes in muscle fibre distribution would have occurred during this period. 8, 9 It is likely that factors either in addition to or other than muscle fibre type are contributing to the magnitude of the SC. One of these factors may include muscle oxidative capacity since the time required to decrease the magnitude of the SC is similar to the time required to increase mitochondrial enzyme activity 10, 11 following endurance training. Additionally, the expression of uncoupling protein 2 (UCP2) and uncoupling 3 (UCP3) may also influence the magnitude of the SC. UCP2 is ubiquitous, 12 and UCP3 is exclusively and abundantly expressed in skeletal muscle. 13 Both uncouple mitochondrial oxidative phosphorylation, 14, 15 which results in the production of heat without an increase in ATP production. Additionally, UCP3 mRNA has been inversely correlated with mechanical efficiency at low submaximal steady-state intensities 16 and found to be lower in endurance-trained rodents 17 and humans 16 compared to normal controls. The possibility, however, that both mitochondrial enzyme activity and UCP3 might have an adverse role in muscle efficiency of exercising healthy individuals during high intensity submaximal exercise has never been addressed. In this study we compared the magnitude of the relative SC with citrate synthase activity, UCP2 and UCP3 mRNA levels and muscle fibre composition in both endurance-trained and recreationally active but non-specifically trained subjects.
Methods

Subjects
Twenty-seven male subjects participated in the study. Twelve subjects were highly trained endurance cyclists (Tr) while 15 were recreationally active, but non-specifically trained (RA). Subjects details are provided in Table 1 . All subjects signed informed consent and volunteered to participate in the present study that was approved by the Deakin University Ethics Committee. The subjects were asked not to participate in any physical activity 24 h prior to testing and to abstain from eating for at least 3 h prior to testing.
Exercise tests
VO 2 peak test. The V O 2 peak test required the subjects to ride at 90 revolutions per min (rpm) on an electronically braked cycle ergometer (Lode Excalibur). This ergometer has a linearity error of approximately 1% across work rates. The subjects began cycling at 50 W for 10 min followed by an increase in work rate of 25 W min 71 until the respiratory exchange ratio (RER) was above 1.1 for 1 min. The work rate was then increased by 13 W min 71 until the subjects could no longer maintain the desired pedal rate. Expired gases were collected and analysed by a Medical Graphics metabolic cart (CardiO2 and CPX=D System) to determine V O 2 and the RER. The metabolic cart was calibrated prior to and after each test using alpha calibrated gases of known concentrations that have an error of 0.01%. The flow sensor was calibrated by flushing air from a 3-l syringe at varying flows and frequencies. The time delay from the mouthpiece to the gas analysers was determined by the Medical Graphics software before each test for direct time alignment for both volume and O 2 and CO 2 concentrations. V O 2 peak was defined either when a plateau in V O 2 with increasing work rates was observed or as the highest 30 s V O 2 value measured during the test. Peak power output (PPO) was deemed as the highest power output at a cadence of 90 rpm that could be maintained for a period of 60 s.
Lactate threshold test. The lactate threshold (LT) test began with each subject cycling at a power output of 40% of PPO. The power output was then increased by 5 -10% of each subject's individual PPO every 4 min until the subject 
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A Russell et al reached volitional exhaustion or when the pedalling cadence could not be maintained at 90 rpm at the given work rate. Prior to exercise a 22-gauge catheter was inserted into an antecubital forearm vein. A 2.5 ml blood sample was taken at rest, immediately after the warm up and at the end of each 4 min workload. The blood samples collected during the LT test were spun in a centrifuge and 10ml of plasma was added to 600 ml of 3 M perchloric acid and spun again. The supernatant (10 ml) was then analysed for plasma lactate in triplicate, using an enzymatic fluorometric technique. 18 The work rate at which plasma lactate accumulation increased by 1 mmol 71 above baseline was defined as the lactate threshold. 19 Constant load test. A constant load test was performed at an intensity approximately 50% between the LT work rate and V O 2 peak work rate for a duration of 6 -10 min. Although the SC occurs at all work rates above the LT during cycling, this intensity has been used previously 3 to quantify the SC (Figure 1 ). The test was stopped when the subjects could no longer maintain the required pedal rate of 90 rpm or when the subject's V O 2 had either reached a plateau or its maximum. A plateau in V O 2 was deemed when V O 2 did not increase by more than 50 ml during the last 2 min of exercise. 20 Calculating the VO 2 slow component The magnitude of the SC has previously been calculated using several different approaches. Mathematical modelling based on both linear and double exponential models 21, 22 has been used, as well as subtracting the V O 2 obtained after 3 min of exercise from either the V O 2 measured after 6 min of exercise or the end-exercise V O 2 . 1, 23 Using the mathematical modelling procedures the start of the SC has been observed to occur after approximately 90 -120 s of exercise. 22 The magnitude of the relative SC is calculated as the difference between the end-exercise V O 2 and the V O 2 value occurring at the start of the SC divided by the difference between end-exercise V O 2 and baseline V O 2 . In the present study the magnitude of the relative SC was calculated using a variation of the formula employed by Barstow et al, 3 as the start of the SC was not determined mathematically, but instead taken as the V O 2 value occurring after 3 min of exercise. Therefore, the magnitude of the relative SC was determined as the difference between the end-exercise V O 2 (EEV O 2 ) and 3 min V O 2 divided by the difference between end-exercise V O 2 and baseline
Muscle sampling, treatment and analysis Skeletal muscle samples were obtained under local anesthesia (xylocaine, 1% plain) from the belly of the vastus lateralis muscle using a percutaneous needle biopsy technique 24 modified to include suction. A single incision was made in the muscle and two muscle samples were taken from a single insertion of the biopsy needle. After the first biopsy cut the needle was rotated and a second cut was performed. Each muscle sample weighed between 50 and 80 mg. One muscle sample was mounted in embedding medium and frozen in isopentane that was previously cooled to its freezing point. These samples were used for histochemical determination of muscle fibre type using a routine myosin ATPase technique. 25 The other muscle samples were quickly frozen and stored in liquid nitrogen for later UCP2, UCP3, b-actin and cytochrome b mRNA analysis. 16 Immediately prior to analysis, part of the latter sample was weighed, homogenised and then freeze -thawed twice. The homogenate was then centrifuged and the supernatant was analysed for citrate synthase (CS) activity using spectrophotometric detection.
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CS activity correlates highly with in vitro measurements of skeletal muscle mitochondrial oxidative capacity 26 and has been commonly used as a marker of muscle oxidative capacity.
27,28
Histochemical staining Serial cross-sections 10 mm thick were cut from the mounted muscle sample in a cryostat maintained at 7 20 C. The sections for fibre typing were preincubated at pH 4.30 and 4.54, and were classified as either type I, IIa or IIx according to the acid lability of different isoforms of myosin adenosine triphosphatase. 25 For each subject, a mean ( AE s.d.) of 439 AE 79 fibres were classified and each fibre type was expressed as a percentage of the total number counted. 29 Oligo-dT primed first strand cDNA was synthesised from 1 mg of total RNA in a 20 ml volume using Superscript ribonuclease II (Rnase H) reverse transcriptase (RT; GIBCO=BRL). One microliter of the reverse transcription reaction mix was amplified with primers specific to the target genes in a 28 ml reaction containing 10ÂPCR buffer, 2.0 mM MgCl 2 , 400 mM dNTP mix and 2 U Taq DNA polmerase (GibcoBRL). The primer sequences starting at 5 0 for the genes of interest included, antisense (gacaacacagtaagaaccagg; size of cDNA ¼ 367 bp). Tests for linearity were performed by removing PCR samples for each gene every two cycles following 24 cycles as well as with increasing the starting amount of cDNA from 0.5 to 1.0, 1.5 and 2.0 ml, respectively. As b-actin is not influenced by training 30 and has been used previously as an internal standard for semiquantitative RT-PCR mRNA analysis, 16 we used it as an internal control and the combinations of UCP3 and bactin, UCP2 and b-actin and cytochrome b and b-actin were amplified in the same PCR reaction, respectively. To ensure that any differences in UCP2 and UCP3 mRNA levels between the Tr and RA groups were not caused by training-induced changes in mitochondrial content, 30 these genes were also expressed relative to cytochrome b. 16 PCR conditions for measuring the target genes for all samples consisted of denaturation at 94 C for 3 min, annealing at 52 C for 70 s and extension at 60 C for 6 min. Each experiment was performed in triplicate with the mean value used for analysis. The PCR products were resolved on a 1.2% agarose gel containing 0.06 mg=ml ethidium bromide. The gels were photographed and the relative concentrations of PCR products were measured by scanning densitometry using a Kodak DC120 digital camera and Kodak Digital Science ID Image Analyses Software (Japan).
Statistical analysis
Where appropriate, unpaired t-tests were used to determine differences between the Tr and RA groups. A univariate ANOVA was used to test for differences in regression slopes between the Tr and RA groups. Pearson correlations were used to establish the strength and direction of the relationship between the magnitude of the relative SC, muscle fibre types, UCP2, UCP3 mRNA expression and CS activity. A Fishers Z-transformation was used to determine if correlations between two variables were different for the Tr and RA groups. All values are reported as means AE standard deviation of the mean (s.d.). All statistics were performed using the SPSS statistical package with criteria for significance set at P < 0.05.
Results
The subjects' physiological characteristics are presented in Table 1 . The effect of chronic endurance training and therefore increased fitness is indicated by a significantly higher V O 2peak , CS activity and lactate threshold power output (LTPO) in the Tr group as compared to the RA group (P < 0.01). The higher LTPO observed in the Tr group resulted in a higher absolute power output required to elict the SC. The Tr subjects also had a greater percentage of type I and a lower percentage of type IIa muscle fibres compared to the RA subjects (P < 0.01).
The correlations between the magnitude of the relative SC and the other independent variables for the Tr and RA groups as well as for the two groups combined are presented in Table  2 . The magnitude of the relative SC of the Tr group had the highest correlation with CS activity (r ¼ 7 0.90, P < 0.001) and that of the RA group with V O 2peak (r ¼ 7 0.68, P < 0.01). As expected a negative correlation was observed between the magnitude of the relative SC and V O 2peak for both groups (r ¼ 7 0.68, P < 0.01). The magnitude of the relative SC and UCP3 mRNA, but not the relative SC and UCP2 mRNA (P > 0.05) were correlated for both the Tr (r ¼ 0.69, P ¼ 0.04) and RA (r ¼ 0.58, P ¼ 0.02) groups. The slopes of the lines for the regressions between the magnitude of the relative SC and UCP3 mRNA for the Tr and RA group were not significantly different (P ¼ 0.27), as was the Pearson correlation coefficients between the magnitude of the relative SC and UCP3 mRNA for the Tr and RA groups (P ¼ 0.71). This analysis indicated that there was no significant difference in the 
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A Russell et al correlation between the magnitude of the relative SC and UCP3 mRNA for theTr and RA groups, therefore these data were combined. The relationship between the magnitude of the relative SC and UCP3 mRNA when the Tr and RA results were combined was r ¼ 0.70, P < 0.01 ( Figure 2 ). The magnitude of the relative SC was lower (P ¼ 0.04) in the Tr as compared to the RA subjects, demonstrating a greater efficiency of aerobic ATP production during submaximal exercise performed above the LT in the former. The Tr subjects also had a lower expression of UCP2 (P ¼ 0.03) and UCP3 (P ¼ 0.04) mRNA as compared to the RA subjects ( Figure 3 ). For the Tr group the magnitude of the relative SC was negatively correlated with the percentage of type I muscle fibres (r ¼ 7 0.58, P < 0.05), while the magnitude of the relative SC of the RA group was positively correlated with the percentage of type IIa muscle fibres (r ¼ 0.59, P < 0.05). These findings confirm previous observations of a relationship between the magnitude of the relative SC and the percentage of type II muscle fibres.
When the groups were combined, the magnitude of the relative SC positively correlated with the percentage of type IIa muscle fibres (r ¼ 0.60, P < 0.01) and negatively with the percentage of type I muscle fibres (r ¼ 7 0.57, P ¼ 0.003; Table 2 ). There was no correlation between the magnitude of the relative SC and the percentage of type IIx muscle fibres for either the Tr or the RA groups respectively, or when the groups were combined (P > 0.05). A positive correlation also existed between UCP3 mRNA and the percentage of type IIa muscle fibres (r ¼ 0.63, P < 0.001; Figure 4 ). There was also a negative correlation between UCP3 mRNA and the percentage of type I muscle fibres (r ¼ 7 0.54, P < 0.01; not shown).
Linear stepwise regression revealed that the magnitude of the relative SC was best explained by CS activity alone, with CS explaining 77% of the variance in the magnitude of the relative SC for the Tr subjects. For the RA group the stepwise linear regression demonstrated that the magnitude of the relative SC was best described by V O 2peak and UCP3 mRNA expression with these variables explaining 73% of the variance of the magnitude of the relative SC. When the Tr and RA groups were combined, 74% of the variance of the magnitude of the relative SC was described also by V O 2peak and UCP3 mRNA expression (Table 3) .
Discussion
The occurrence of the SC during submaximal exercise performed above the LT results in a delay and=or the prevention of steady-state V O 2 and is associated with premature exhaustion. The SC is known to be reduced after endurance training 6, 7 when exercising at the same pre-training work rate 
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A Russell et al above the LT. This reduction in the SC may demonstrate a better mechanical efficiency and=or efficiency of aerobic ATP production at work rates above the LT. The use of the term mechanical efficiency is this context is not to be confused with the 'classic' mechanical efficiency often measured at work rates below the LT, as a steady-state V O 2 is required for a measurement of mechanical efficiency. The present study observed a lower relative SC in a group of Tr subjects, who possessed a greater level of aerobic fitness when compared to a group of RA subjects. The superior fitness levels of the Tr group as compared to the RA group was evident as the Tr group had a larger V O 2 peak, increased CS activity and a higher LTPO. Although the lower relative SC in the Tr when compared to the RA group is best explained by differences in aerobic fitness, the present study cannot rule out the possibility that other factors contributed to this finding, such as a difference in relative exercise intensity between the groups (see below). The magnitude of the relative SC of the Tr group correlated negatively with both CS activity and the percentage of type I muscle fibres and positively with UCP3 mRNA expression. However, linear stepwise regression revealed that the magnitude of the relative SC of the Tr group was best explained by CS activity alone, with CS explaining 77% of the variance of the magnitude of the relative SC. CS activity is a marker of muscle oxidative capacity 27, 28 and these correlations imply that the greater the CS activity, the smaller will be the size of the relative SC for endurance trained subjects. Although these findings do not indicate a causal link, it is reasonable to speculate that the lower SC is in response to an increase in the oxidative capacity of the contracting muscle. The positive correlation between the magnitude of the relative SC and UCP3 mRNA may be explained by the uncoupling activity of the UCP3 protein.
Although the activity of the UCP3 protein has not been determined, it is possible that a lower expression of the UCP3 mRNA will result in a tighter coupling of the mitochondria which may enhance the muscles' ability to maintain a higher ATP=ADP ratio, therefore reducing mitochondrial respiration and attenuating the relative SC in the Tr subjects.
For the RA subjects the magnitude of the relative SC correlated negatively with V O 2peak and positively with UCP3 mRNA expression and the percentage of type IIa muscle fibres. A stepwise linear regression demonstrated that the magnitude of the relative SC for the RA group was best described by V O 2peak and UCP3 mRNA expression with these variables explaining 73% of the variance of the magnitude of the relative SC. V O 2peak is an indicator of aerobic fitness and a larger V O 2 has previously been associated with a smaller SC in RA subjects. 3 Unlike the Tr group, muscle oxidative capacity, as indicated by CS activity did not correlate with the relative SC of the RA group. Instead, total body oxidative capacity as indicated by V O 2peak was a stronger predictor of the magnitude of the relative SC in RA subjects. For the Tr group, CS rather than V O 2peak may have been a better predictor of the magnitude of the relative SC due to the fact that after chronic endurance training V O 2peak reaches a ceiling. 31 Following this, improvements in endurance performance or time to fatigue are then influenced by an increase in enzyme activity such as CS. 32 When the Tr and RA groups were combined, UCP3 mRNA positively correlated with the magnitude of the relative SC, suggesting that mitochondrial uncoupling may play a role in the magnitude of the relative SC irrespective of training status. As the putative function of the UCP3 protein is to uncouple oxidative phosphorylation a lower expression of the UCP3 protein would result in better mitochondrial coupling, a reduction in the magnitude of the relative SC and therefore more efficient aerobic ATP production during submaximal exercise above the LT. Recently, a negative correlation between UCP3 mRNA and mechanical Figure 4 The relationship between UCP3 mRNA expression and the percentage of type IIa muscle fibres (r ¼ 0.63, P ¼ 0.001) when both Tr and RA groups are combined (n ¼ 24). 
A Russell et al efficiency was reported during low-intensity steady-state exercise. 16 Taken together, these results suggest that UCP3 may be a good candidate to explain inter-individual differences in the efficiency of aerobic ATP production during submaximal exercise performed below and above the LT. It is noteworthy that an observed change in mRNA does not necessarily indicate a change in the expression or the activity of the protein. Presently commercially available anti-UCP3 antibodies are not sensitive enough to allow the measurement of UCP3 protein in the small amount of protein obtained from human muscle biopsies. The effect of endurance training on UCP3 protein expression therefore remains to be investigated.
The magnitude of the relative SC of the Tr and RA groups was negatively correlated with the percentage of type I muscle fibres and positively correlated with the percentage of type IIa muscle fibres, respectively, a finding in agreement with previous observations. 3 The SC response of the V O 2 profile is indicated by a delay in a secondary phase of oxygen uptake. Although speculative, the relationship between this delayed V O 2 response may be explained in part, by the progressive recruitment of type II muscle fibres to maintain a given work rate as the type I fibres are gradually fatigued. On the other hand all fibres may be recruited at the start of exercise, however there may be a progressive increase over time in the neural stimulation of the type II fibres. As type II muscle fibres are less efficient than type I muscle fibres and posses an 18% lower phosphate produced to oxygen consumed ratio (P:O 2 ratio), 33, 34 recruitment of these fibres would result in more oxygen consumption when required to maintain a given work rate. No correlation existed between the magnitude of the relative SC and the percentage of type IIx muscle fibres for the either the Tr or the RA groups, or when both groups were combined. The reason for this lack of a relationship is unclear, however it may be due to the very small percentage of type IIx muscle fibres in the Tr and RA groups, which was 8 and 9%, respectively. Consequently the contribution of type IIx fibres to the SC is likely to be minor.
UCP3 mRNA expression was lower in the Tr compared to the RA group, which supports observations by others. 16, 17 We also observed that the magnitude of the relative SC in both the TR and RA groups was positively correlated with UCP3 mRNA expression and also confirmed the positive correlation between the magnitude of the relative SC and the percentage of type II muscle fibres. As UCP3 mRNA expression is higher in rat type II compared with type I muscles, 13 we thought it interesting to investigate the relationships between the UCP3 mRNA levels and muscle fibre type composition. There was no correlation between UCP3 mRNA and muscle fibre type in the Tr group, however UCP3 mRNA was positively correlated with the percentage of type IIa muscle fibres in the RA group. The reason for the lack of correlation between UCP3 mRNA and muscle fibre type in the Tr group is unclear, however it may be due to the effect of endurance training down-regulating UCP3 mRNA expression to a similar level in all muscle fibre types. The positive correlation between UCP3 mRNA and the percentage of type IIa muscle fibres is consistent with the observations made in rodents that type II muscles contain more UCP3 mRNA. 13 Additionally, it supports the notion that the mechanisms causing the relative SC, are localised within the contracting muscle 3, 4, 35 and provides a possible cause, at least in part, of the relative SC for RA subjects.
The SC causes premature fatigue in both healthy individuals and patients suffering from hypertrophic cardiomyopathy and chronic obstructive pulmonary disease (COPD), however the SC occurs at much lower work rates in the latter. 36, 37 Recently it was observed that exercise intolerance in COPD patients was strongly correlated with a progressive reduction in CS activity, demonstrating a reduced oxidative capacity. 38 It is possible the over-expression of UCP3 may also contribute to the exercise intolerance observed in these patients when exercising at low work rates. Interestingly, many COPD patients have an increase in blood fatty acids, 39 which have been shown to upregulate UCP3 mRNA. 40, 41 Although only speculation, the uncoupling role of UCP3 may be involved in the development of the SC at low work rates in COPD patients. The investigation of UCP3 expression in COPD patients may provide more evidence as to the mechanisms causing various skeletal muscle myopathies.
The slow component of the V O 2 response has been observed to delay and=or inhibit the attainment of steadystate V O 2 and is associated with premature fatigue. In the present study the RA subjects were either exhausted or reached V O 2max , while many of the Tr subjects obtained a plateau in V O 2 . Therefore it is possible that the two groups may not have been exercising at the same relative intensity and our results must be interpreted with this in mind. We attempted to set the relative intensity for both groups at 50% of the difference between the LT and V O 2peak power outputs as this intensity has been shown to produce a SC, 22, 42 however there are always methodological concerns when trying to normalise exercise intensities between two different groups. However, our study has provided some novel findings both within and between the Tr and RA groups. For example the magnitude of the relative SC of the Tr group was best described by CS activity as opposed to muscle fibre type or UCP3 mRNA expression. The magnitude of the relative SC for the RA group was best described by V O 2peak and UCP3 mRNA expression. It appears that the training status of the individual will determine which factors influence the magnitude of the relative SC. These inter-group differences should be considered for future studies aimed at determining a cause and effect relationship for the relative SC. Our results have also suggested that UCP3 may influence the magnitude of the relative SC in RA subjects as well as the oxidative efficiency of the different fibre types. Sport, by the Roche Research Foundation and the Helen Schutt Trust.
